Orbitofrontal Cortex: A 'Non-rewarding' New Treatment Target in Depression?
Self-perpetuating activity in lateral orbitofrontal regions has been theorized to sustain the negative thoughts and emotions of depression. A new study demonstrates that disrupting such activity may yield rapid improvements in mood state, pointing the way to novel treatment strategies.
The last 25 years have seen major advances in research on major depression -both in terms of our understanding of the networks of brain regions affected by the disorder, and in terms of our ability to stimulate those networks for therapeutic effect. Recently, the orbitofrontal cortex has drawn increasing interest both for its role in signaling 'non-reward' in depression and for its potential as a therapeutic target for novel brain stimulation interventions. As recently published in Current Biology, Rao et al. [1] have now provided the first direct evidence for a specific electrophysiological marker of negative mood states emerging from the orbitofrontal cortex, as well as direct causal evidence that disrupting this activity yields immediate improvements in mood state. Target brain regions for depression first emerged in early 1990s neuroimaging studies, which have always closely informed the development of new brain stimulation treatments -perhaps most famously with the identification of the overactive subgenual anterior cingulate cortex as a target for deep brain stimulation [2] , and with the identification of the underactive left dorsolateral prefrontal cortex as a target for repetitive transcranial magnetic stimulation (rTMS) [3] .
More recent work has emphasized abnormalities at the level of whole-brain networks rather than specific regions. For example, patients with depression have shown increased correlations between the subgenual anterior cingulate cortex and the default-mode network [4] , and between the default-mode network and two other functional networks via a 'dorsal nexus' near the dorsomedial prefrontal cortex [5] . The latter region, once again, subsequently developed into a target for rTMS to treat depression [6] . The increasing profusion of targets may reflect a fundamental heterogeneity in the neural substrates of major depression itself. A recent yet widely-cited study [7] in >1000 depressed patients found that they could be reliably sorted into four 'biotypes' based on unique signatures of whole-brain functional connectivity revealed by resting-state functional magnetic resonance imaging (fMRI). Two of these biotypes responded well to dorsomedial prefrontal cortex rTMS, while the others responded poorly. Notably, one of the non-responding types showed an abnormal nexus of activity not within the dorsomedial prefrontal cortex, but rather in a region of recent growing interest in depression research: the lateral orbitofrontal cortex ( Figure 1A -C).
The orbitofrontal cortex is a large, ancient, and heterogeneous cortical region for which a variety of functions have been studied over the years, ranging from olfaction to motivation and reward, modulation of limbic and autonomic activity, and the regulation of emotional states (for reviews see [8] [9] [10] ). One such function involves the signaling of 'non-reward' rather than reward: just as a classically described ventral striatal-ventromedial prefrontal 'reward circuit' signals better-thanexpected outcomes, an analogous ventral striatal-lateral orbitofrontal 'nonreward circuit' signals worse-thanexpected outcomes, such as missed rewards, losses, or aversive stimuli [11] . In one elegant and colourful illustrative study [12] using positron emission tomography (PET), volunteer chocolate lovers were sequentially fed chocolate in the scanner to well beyond the point of satiety; as the chocolate stimuli shifted from pleasurable to aversive, activation shifted from medial to lateral orbitofrontal cortex.
The non-reward signaling functions of the lateral orbitofrontal cortex may have relevance to the pathophysiology of depression. For example, in a well-cited fMRI study [13] , during successful (A) The lateral orbitofrontal cortex participates in a network of regions whose function has been linked elsewhere to 'non-reward' signaling [11] . (B) One of four recently-demonstrated 'biotypes' of depression shows an abnormal nexus of connectivity in the right orbitofrontal cortex. Reprinted by permission from Springer Nature: Nature Medicine [7] . (C) The same abnormal nexus appeared in a recent resting-state fMRI study of hundreds of patients with major depression by an independent group of authors. From [14] by permission of Oxford University Press. (D) In the study of Rao et al. [1] , higher theta-and alpha-band power on intracranial EEG recordings correlated with worse ratings of negative mood state and negative thought content. (E) In the same study [1] , suppression of this lateral orbitofrontal alpha-band and theta-band activity using high-frequency (100 Hz) stimulation via implanted intracranial electrodes yielded immediate improvements in mood state among patients with moderate to severe symptoms of depression.
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Dispatches reappraisal of negative emotional scenes, healthy volunteers activated the lateral orbitofrontal cortex, which in turn reduced the activity of the amygdala to reduce the intensity of the negative emotion. However, when depressed patients activated the same lateral orbitofrontal cortex region, amygdala activity and negative emotion ratings paradoxically increased. Such observations have evolved into Rolls' [11] recent proposal of a 'non-reward attractor theory of depression', in which re-entrant activity in the lateral orbitofrontal non-reward circuit could perpetuate the negative emotional bias, recurrent hopeless thoughts, and negative ruminations encountered in depressed patients. In support of this proposal, Cheng et al. [14] recently identified an abnormal nexus of resting-state functional connectivity in lateral orbitofrontal cortex in a large sample of adults with depression ( Figure 1C ).
Taken together, these findings suggest that at least a subset of depressed patients may have pathology driven by re-entrant activity in a lateral orbitofrontal cortex 'non-reward' pathway. If so, then two key questions would be whether disruption of activity in the lateral orbitofrontal cortex might be therapeutically useful in reducing depression symptoms, and whether it might be possible to identify a biomarker of the re-entrant activity that would allow for real-time monitoring of the treatment effect, and perhaps for optimization or personalization of the stimulation parameters in individuals.
These two issues are the subject of the important new breakthrough. Rao et al. [1] studied 25 epilepsy patients who had undergone implantation of intracranial electroencephalography (iEEG) electrodes in the region of the orbitofrontal cortex for presurgical mapping. Many of these patients had significant depression symptoms, scoring in the moderate-to-severe range on standard clinical scales. The authors began by sampling their mood state using a short questionnaire at regular intervals during the days of iEEG recording, and found that patients' natural hour-to-hour and day-to-day mood fluctuations correlated with activity in the lateral orbitofrontal cortexspecifically, more negative mood correlated with higher iEEG power in the low-frequency (theta and alpha) bands ( Figure 1D ).
Next, Rao et al. [1] delivered 100-200 second runs of high-frequency (100 Hz) electrical stimulation at a variety of intensities to a variety of electrodes across orbitofrontal cortex and nonorbitofrontal cortex brain regions, and found that stimulation of the lateral orbitofrontal cortex suppressed thetaand alpha-band activity, yielding immediate improvements in mood and suppression of negative thought content during the period of stimulation ( Figure 1E ). This effect was seen for both left and right lateral orbitofrontal cortex stimulation, and to a lesser extent for other regions implicated in depression such as the dorsal cingulate cortex and anterior insula, but not for other regions. The antidepressant effect was seen only in those patients with moderate to severe depression symptoms. There was no mood-elevating effect in those without depression symptoms, and no evidence of induced symptoms of mania, suggesting that the effect was specifically to disrupt negative thought content and mood state. Notably, there seemed to be some durability to the effect beyond the period of stimulation itself: single pulses of stimulation delivered to lateral orbitofrontal cortex regions elicited larger evoked potentials after the train of stimulation, compared to before the train of stimulation. No such effect was seen for stimulation of a comparator region in the precentral gyrus.
These intriguing observations are among the first direct demonstrations of antidepressant effects for stimulation of the lateral orbitofrontal cortex, and the first to employ the direct and anatomically focal technique of intracranial stimulation in this region in patients with depression. They are also the first to use both correlational and causal methods to link negative emotional states to a specific iEEG marker at a specific site: namely, high theta-and alpha-band power in the lateral orbitofrontal cortex. In support of the 'non-reward attractor theory of depression', disruption of these lowfrequency oscillations also successfully disrupted the negative thought content in those patients where it was present.
Although these observations will require further replication in a larger sample of patients (preferably without comorbid epilepsy), an attractive feature of the findings is that both the stimulation technique and the candidate biomarker can be readily adapted to non-invasive methods. The lateral orbitofrontal cortex lies near the surface, at a scalp site where non-invasive EEG signals can be readily acquired in the theta and alpha bands. The superficial location of the lateral orbitofrontal cortex also facilitates non-invasive stimulation with techniques such as transcranial electrical stimulation (tES) or rTMS, enabling both mechanistic studies and clinical studies of the therapeutic effects of non-invasive orbitofrontal cortex stimulation.
Indeed, small studies of lateral orbitofrontal cortex-rTMS have already been conducted, including a study in patients with obsessive compulsive disorder (OCD) including PET scans demonstrating metabolic suppression of activity in the target region [15] , and cases in depression, demonstrating disruption of lateral orbitofrontal cortex-ventral striatal connectivity [16] as well as reduction in depression symptoms in patients who had already failed to respond to rTMS of more commonplace dorsal prefrontal targets [17] .
Further work will be needed to replicate these observed therapeutic effects under randomized controlled conditions, and to determine whether theta-and alpha-band power on EEG can serve as a reliable marker for predicting and/or tracking the therapeutic response in individual patients. Studies using modeling and simulations may also be helpful to determine what patterns of stimulation would be most effective for disrupting activity in these frequency bands specifically [18] . If successful, the end result may be a 'closed-loop', non-invasive treatment that directly targets the orbitofrontal cortex substrates of excessive, self-perpetuating non-reward signaling in patients with this crippling illness.
The basal ganglia integrate motivation and action across their circuits; neurons in anatomical modules called striosomes could contribute strongly to this merger. A new method focusing on network interconnections will allow a better understanding of the functional role of striosomes.
Motivation plays an important role in our daily actions. For example in sports, let's say you're about to serve for a key point in a tennis match: you really want to get that first serve in. Motivation and action circuits in the brain will need to quickly interact. On a longer timescale, say you must decide if you're going to exercise your right on election day -you are, and you will make sure to give your support to your best candidate. Both these examples show that motivation plays a major role in shaping behavioral actions: every day we make motivated decisions that begin with cognition and end with action. The brain's basal ganglia are an important nexus for this motivation/action interface.
The input structure of the basal ganglia, the striatum, contains neurons that receive information about both motivation and action, located in a compartment called striosomes. Distributed sinuously across the striatum like spaces in swiss cheese, this compartment shows a distinct scattered anatomical pattern ( Figure 1B ). While striosomes have been well characterized anatomically in many species, data concerning their electrophysiology and functionality have been elusive. In the non-human primate, where much knowledge of the cognition/ action interface has been explored at the neuronal level, the scattering of striosomes and their depth in the brain present a localization challenge (see
